NOTE MODIFICATION AND FOREBAREANCE AGREEMENTNote Modification and Forbearance Agreement • May 26th, 2020 • Endonovo Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 26th, 2020 Company Industry JurisdictionNote Modification and Forbearance Agreement, dated as of May 20, 2020, by and among Endonovo Therapeutics, Inc., a Delaware corporation, with an address of 6320 Canoga Avenue - 15th Floor, Woodland Hills, CA 91367 (“ENDV”) and the party set forth on the signature page hereto (the “Lender”);